A new intravenous safflower oil emulsion (Liposyn, Abbotl) was administered to 23 patients receiving total parenteral nutrition. In a prospective clinical trial, 500 ml of the 10% emulsion was administered each day for a minimum of 10 days. Plasma fatty acid estimations showed a rise in linoleic acid in 22 patients, and a fall in trieneltetraene ratio (a guide to the presence of essential fatty acid deficiency), in 17 patients within four days of commencement of the infusion. Administration of Liposyn prevented the development of biochemical evidence of essential fatty acid deficiency. There were no clinical side effects attributable to the emulsion. Elevation of serum triglyceride and liver enzyme concentrations occurred in some patients.
does not require storage under refrigeration. This paper reports the results of a clinical study in which Liposyn was administered to patients as part of their total parenteral nutrition regimen.
MATERIALS AND METHODS A total of 23 patients who required total parenteral nutrItion as part of their management for a variety of medical and surgical conditions were studied.
Each patient was given of his or her daily caloric requirements as linoleate on each day of the study, which proceeded for a minimum of 10 days in each case. The fat emulsion used was Liposyn 10070, supplied by Abbot! Laboratories, Chicago. It was maintained at a temperature below 30 QC. In patients 1-8 (Group 1) the emulsion was infused at a rate of 42-84 mllhour, 500 ml being administered in not less than 6 and not more than 12 hours. Six of these patients were critically ill in an intensive care unit. In patients 9-23 (Group 2) the emulsion was infused at a rate of 21 mllhour, 500 ml being administered evenly over 24 hours. These patients were in general wards, as were the remaining two patients in Group 1.
Anaesthesia and Inll'mive Care, Vol. X, No. 3, AugUSI, 1982 Patients with abnormal laboratory values for serum triglycerides, serum cholesterol, liver function or coagulation tests, were excluded from the study, as were those with clinical hyperlipoproteinaemia, hepatic disease, diabetes mellitus, or acute pancreatitis. Administration of all solutions was by way of a central venous catheter. The amount and source of nitrogen, electrolytes and vitamins provided was at the discretion of the investigator. Vitamins not included in the regimen, such as vitamins B 12 , K, and folic acid were administered intramuscularly in an amount and frequency determined by the investigator .
Clinical observations included hourly pulse, blood pressure, respiratory rate and temperature during the infusion and for 5 hours thereafter in Group 1. In Group 2 these observations were taken before and at one hour after commencement of the infusion, and thereafter 4th hourly on the first day. Subsequently, observations were taken at less frequent intervals.
Routine urinalyses were performed. Laboratory investigations included haemoglobin, red blood cell, white blood cell and platelet counts, activated partial thromboplastin time, prothrombin time, serum sodium, potassium, chloride, bicarbonate, urea, creatinine, uric acid, serum alanine transferase, aspartate aminotransferase, gamma-glut amyl transferase, lactic dehydrogenase, alkaline phosphatase, total bilirubin, total protein, albumin, cholesterol, triglycerides, calcium, magnesium, phosphate and glucose. These measurements were carried out daily for Group 1, and on days 1, 3, 5, 8 and 15 for Group 2 patients. Serum haptoglobins, blood gases and osmolality were measured at intervals. D. G. T ABRETT AND G. D. PHILLIPS Plasma total fatty acid composition was determined by gas liquid chromatography, and the triene/tetraene ratio calculated as the ratio of 5, 8, 11 eicosatrienoic acid (20:3w9) to arachidonic acid (20:4w6). The absolute concentrations of these two acids and that of linoleic acid (18:2w6) were also measured. These measurements were carried out on the day prior to commencement of the infusion, and at intervals of 3-4 days during the study.
Approval for the study was given by the relevant research committees of each hospital, and informed consent was obtained from each patient.
RESULTS
Each patient's age, sex, diagnosis, calorie and nitrogen intake are given in Table 1 .
There were no abnormalities of pulse, blood pressure or temperature observed during the infusions in either group that could be attributed to the Liposyn infusion.
Group 1
All laboratory investigations were within normal limits, with the exception of the following:
Two patients had low platelet counts at the commencement of the study, one due to massive transfusion and one due to septicaemia. The counts increased rapidly during the first few days of the study. Four patients had slightly prolonged prothrombin times at the commencement of the study. These had improved in all patients by the end of the study period.
Serum alanine transferase increased in five out of eight patients, by as much as 20 times the pre-infusion value. Serum bilirubin concentration increased in six out of eight patients by as much as 10 times the pre-infusion values. The most consistent changes were in serum gamma-glutamyl transferase and serum alkaline phosphatase concentrations, both of which increased in all patients studied.
Plasma concentrations of linoleic acid increased markedly in all patients except one, between days 0 and 4. In that patient the prestudy value was already high. Concentrations then either plateaued or fell by day 10-14 (Table   2 ).
Triene/tetraene ratios fell in five patients and rose in three, between days 0 and 4 ( Table 3) . There was a further fall between days 4 and 10-14 in four patients. The changes in triene/tetraene ratio were sometimes due to changes in the concentration of eicosatrienoic acid and sometimes of arachidonic acid (Table  4 ). Essential fatty acid deficiency (triene/tetraene ratio > 0.3) was present in only one patient at the commencement of the study, and this became normal within 4 days.
Serum triglyceride concentrations rose in two patients between days 1 and 5 then fell ( Table   5 ). 
Group 2:
Seven patients showed a marked increase in serum triglyceride concentrations, peaking at around 3-5 days, and thereafter falling to within the normal range with continued administration of Liposyn ( Table 5 ). Three of these patients transiently demonstrated morphological changes in their peripheral blood films similar to those described with infusion of 20OJo Intralipid. 5 These changes included red cell pseudoagglutination, stomatocytosis, spherocytosis and loss of membrane definition. Loss of granulocyte membrane definition, and abnormal platelets were also seen. The abnormalities in serum alanine transferase, serum bilirubin, and serum alkaline phosphatase concentrations seen in Group 1 were not observed in this group.
As in Group 1, plasma concentrations of linoleic acid increased markedly in all patients between days 0 and 4. Concentrations then either plateaued or fell by day [10] [11] [12] [13] [14] (Table 2) .
Triene/tetraene ratios fell in 12 patients and remained unchanged in three, between days 0 and 4 ( Table 3 ). There was a further fall between days 4 and 10-14 in 13 patients. The changes in triene/tetraene ratio were sometimes due to changes in the concentration of eicosatrienoic acid and sometimes of arachidonic acid ( Table 4 ).
The triene/tetraene ratio was greater than 0.3 in two patients at commencement of the study, and the ratio became normal within 4 days.
DISCUSSION

Group J -Intermittent Infusion of Liposyn
The patients in Group 1 included six who were critically ill in an intensive care unit, and two with carcinoma of the stomach receiving preoperative total parenteral nutrition.
Anaesthesia and Infensive Care, Vol. X, No. 3, August, 1982 Abnormalities in clinical observations and laboratory results were considered to be within the range expected in such patients. Derangement of liver function tests is frequently observed in critically ill patients and in patients receiving parenteral nutrition without fat infusion and with infusion of lipids derived from soybean and cottonseed oils. 4 Various mechanisms have been proposed to explain the abnormal liver function tests including hepatocellular damage, cholestasis, fatty infiltration, and amino acid toxicity. 6 While it is possible that the fat infusion contributed to the liver function test picture, it is quite likely it did not.
Only one patient in Group 1 had a triene/tetraene ratio of greater than 0.3 at commencement of the study. In all eight patients studied there was no biochemical evidence of essential fatty acid deficiency at the conclusion of the study.
Group 2 -Continuous Infusion of Liposyn
The patients in Group 2 suffered from a variety of disease processes, but were not ill enough to require intensive care. The main abnormality which developed during the study in half of the patients was an increase in serum triglyceride concentration between days 3 and 5, which fell as the study progressed. That this rise was not a common feature in Group 1 patients is explicable by the fact that in Group 1 the fat infusion was intermittent and in Group 2 it was continuous. Elevation of serum triglyceride concentrations during continuous Liposyn infusion has been reported previously. 7 Intermittent infusion of Intralipid 10070 is associated with a marked increase in serum triglyceride concentrations, which fall to preinfusion values within a few hours of cessation of infusion. 8 Increase in serum triglyceride concentrations has been observed to occur during fat-free total parenteral nutrition. 2 The morphological changes observed in the peripheral blood film of three patients appeared to correlate with an abrupt rise in plasma triglyceride values. One other patient demonstrated the changes without any apparent increase in triglyceride concentrations. Conversely, not all those with elevated triglyceride concentrations showed morphological changes in their blood film. the presence of essential fatty acid deficiency, although the content of eicosatrienoic acid in tissues can be depressed by dietary fatty acids other than linoleic. The upper limit of normal for the triene/tetraene ratio is often regarded as 0.4, although Holman 9 now regards 0.3 as the upper limit of normal, the average being closer to 0.1. Of the fat emulsions currently available, the most widely used in most countries is the soybean derivative Intralipid ( Table 6 ). The principal difference between safflower oil and soybean oil is the high content of linoleic acid, and the absence of linolenic acid in the former (Table 7) .
Safflower oil is theoretically better at preventing or treating essential fatty acid Anaesthesia and Intensive Care, Vol. X, No. 3, August, 1982 deficiency than other oils since it contains no linolenic acid, which has been shown to competitively inhibit the metabolism of linoleic acid. IO However, linolenic acid is known to be an essential fatty acid in animals. 4 There have been several reports of use of safflower oil emulsion. Bivins et 0/. 11 reported its use in 15 surgical patients requiring parenteral nutrition for 2-4 weeks. They found sporadic mild deviations in liver function in several patients but no abnormalities in other biochemical parameters or clinical observations. Apelgren et 0/. 12 administered Liposyn to seven surgical patients requiring parenteral nutrition for a minimum of 28 days, and found no adverse reactions. A detailed metabolic study during administration of Liposyn to eight surgical patients revealed no deleterious effects. I3 Fifteen normal male volunteers who received a Liposyn infusion were divided into three groups who received either single or multiple daily infusions. Serum triglycerides were elevated in most subjects in all groups, but the elevations were minimised by adding 1-2 U heparin per ml of Liposyn.1 4 This study supports those cited above in showing that Liposyn fat emulsion is safe, and effective in preventing the development of biochemical evidence of essential fatty acid deficiency. In the light of increasing evidence of the metabolic complications of glucose loads,15 the development of lipid calorie sources is welcome.
